Galectin-3 links microglial neuroinflammation to Aβ aggregation and lysosomal processing

Neuroinflammation is a hallmark of Alzheimer’s disease (AD), yet the molecular mechanisms linking microglial dysfunction to amyloid-β (Aβ) pathology remain incompletely understood. Here, we identify galectin-3 (Gal3) as a regulator of plaque-associated microglial responses, linking Aβ aggregation, lysosomal function, and neuritic pathology. Using postmortem brain tissue from AD patients, we found that Gal3 + microglia preferentially associate with cored plaques and correlate with increased LAMP1 + dystrophic neurites. Gal3 was also detected in microglial lysosomal compartments, extramicroglial dystrophic structures, and in association with extracellular amyloid fibrils, suggesting roles in both intracellular and extracellular Aβ processing. In APP mice, Gal3 deficiency reduced plaque burden and neuritic dystrophy, increased plaque compaction, and enhanced TREM2 coverage around amyloid plaques. Mechanistically, in vitro microglial experiments showed that Gal3 modulates Aβ uptake and lysosomal processing, whereas lysosomal dysfunction promoted the accumulation of fibrillar Aβ from initially monomeric species, particularly in Gal3-deficient cells. Cell-free assays demonstrated that Gal3 preferentially binds fibrillar Aβ, inhibits secondary nucleation, and alters fibril morphology, while Gal3-modified fibrillar Aβ reduces N2a neuronal cell number. Finally, in silico structural analyses identified candidate Gal3 interactors enriched in leucine-rich-repeat and immunoglobulin-like proteins, supporting a role for this lectin in immune receptor regulation. Complementary in vivo transcriptomic profiling showed that Gal3 deletion suppresses type I interferon and microglial neurodegenerative transcriptional signatures. Together, these findings position Gal3 at the interface between Aβ remodeling, lysosomal homeostasis, and plaque-associated microglial responses in AD.

Authors

Institutions

Publication Details

Journal
Proceedings of the National Academy of Sciences
Published
2026-11-18
DOI
https://doi.org/10.1073/pnas.2625362123
Citations
1
Primary Topic
Neuroinflammation and Neurodegeneration Mechanisms
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Galectin-3 links microglial neuroinflammation to Aβ aggregation and lysosomal processing

Ángela Gómez-Arboledas, Emil Axell, Lluís Camprubí-Ferrer, Yiyi Yang et al.
1 citations
Proceedings of the National Academy of Sciences
Neuroinflammation and Neurodegeneration Mechanisms
article

Galectin-3 links microglial neuroinflammation to Aβ aggregation and lysosomal processing

Ángela Gómez-Arboledas, Emil Axell, Lluís Camprubí-Ferrer, Yiyi Yang, Gabriel A. Rabinovich, Marta García-Cruzado, Oxana l. Klementieva, Rosalía Fernández‐Calle, Rocío Talaverón, Javier Vitórica, Gunnar K. Gouras, Tomas Deierborg, Juan García‐Revilla, Javier Frontiñán-Rubio, Antonio Boza‐Serrano, Malin Wennström, Antonia Gutiérrez, Jose Luis Venero, Jesús Soldán-Hidalgo, Logan Larlham
article en
1 citations

Abstract

Neuroinflammation is a hallmark of Alzheimer’s disease (AD), yet the molecular mechanisms linking microglial dysfunction to amyloid-β (Aβ) pathology remain incompletely understood. Here, we identify galectin-3 (Gal3) as a regulator of plaque-associated microglial responses, linking Aβ aggregation, lysosomal function, and neuritic pathology. Using postmortem brain tissue from AD patients, we found that Gal3 + microglia preferentially associate with cored plaques and correlate with increased LAMP1 + dystrophic neurites. Gal3 was also detected in microglial lysosomal compartments, extramicroglial dystrophic structures, and in association with extracellular amyloid fibrils, suggesting roles in both intracellular and extracellular Aβ processing. In APP mice, Gal3 deficiency reduced plaque burden and neuritic dystrophy, increased plaque compaction, and enhanced TREM2 coverage around amyloid plaques. Mechanistically, in vitro microglial experiments showed that Gal3 modulates Aβ uptake and lysosomal processing, whereas lysosomal dysfunction promoted the accumulation of fibrillar Aβ from initially monomeric species, particularly in Gal3-deficient cells. Cell-free assays demonstrated that Gal3 preferentially binds fibrillar Aβ, inhibits secondary nucleation, and alters fibril morphology, while Gal3-modified fibrillar Aβ reduces N2a neuronal cell number. Finally, in silico structural analyses identified candidate Gal3 interactors enriched in leucine-rich-repeat and immunoglobulin-like proteins, supporting a role for this lectin in immune receptor regulation. Complementary in vivo transcriptomic profiling showed that Gal3 deletion suppresses type I interferon and microglial neurodegenerative transcriptional signatures. Together, these findings position Gal3 at the interface between Aβ remodeling, lysosomal homeostasis, and plaque-associated microglial responses in AD.

Proceedings of the National Academy of SciencesVol. 123(47)
Consejo Superior de Investigaciones Científicas (ES), Lund University (SE), Universidad de Buenos Aires (AR), Instituto de Salud Carlos III (ES), Biomedical Research Networking Center on Neurodegenerative Diseases (ES), Centro de Investigación Biomédica en Red (ES), Instituto de Biomedicina de Sevilla (ES), Hospital Universitario Virgen del Rocío (ES), Instituto de Investigación Biomédica de Málaga (ES), NanoLund (SE), CaixaResearch Institute (ES), Experimental Medicine and Biology Institute (AR), University of Castilla-La Mancha (ES), Universidad de Sevilla (ES), Universidad de Málaga (ES)
Universidad de Sevilla, Universidad de Málaga, Ministerio de Ciencia, Innovación y Universidades, Fundación Sales, European Commission, National Science Council, Fondation pour la Recherche Médicale, Crafoordska Stiftelsen, Lunds Universitet, Linköpings Universitet, Knut och Alice Wallenbergs Stiftelse, Stiftelsen Olle Engkvist Byggmästare, Kungliga Tekniska Högskolan, Vetenskapsrådet, Ministerio de Ciencia e Innovación, Universidad de Buenos Aires, Greta och Johan Kocks stiftelser, Swedish Brain Power, Universidad de Castilla-La Mancha, Alzheimerfonden, Fundación Bunge y Born, Anna och Edwin Bergers Stiftelse, Fundación René Barón, Junta de Andalucía, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Parkinsonfonden, Instituto de Salud Carlos III, National Supercomputer Centre, Linköpings Universitet
Good health and well-being
Neuroinflammation and Neurodegeneration Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon